Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Posted on by Pencis

Prof. Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Prof. Wei Eric Wang, Southwest Hospital, Army Medical University, China

Prof. Wei Eric Wang is a distinguished medical professional based at Southwest Hospital, Army Medical University, in China. Renowned for his expertise in medical research and clinical practice, he has contributed significantly to the fields of surgery, healthcare management, and medical education. With numerous publications in peer-reviewed journals, Prof. Wang has established a reputation for pioneering studies in his area of specialization. He is also actively involved in advancing medical training, and his leadership at the hospital continues to shape healthcare innovation in China. His work has earned him recognition both nationally and internationally.

AUTHOR PROFILE

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS:

Dr. Wei (Eric) Wang pursued his medical education at the Third Military Medical University in Chongqing, China. He earned his M.D. in Clinical Medicine from 2000 to 2005. Following this, he completed his Ph.D. at the Institute of Burn Surgery, Southwest Hospital, at the same university between 2005 and 2010. His early academic endeavors laid the foundation for his expertise in cardiology and geriatric medicine.

🏥PROFESSIONAL ENDEAVORS:

Dr. Wang has held various prestigious positions throughout his career. He has been the Director of the Department of Geriatrics at Southwest Hospital since November 2022, demonstrating his leadership in the field. Prior to this, he served as Chief Physician and Professor in the Department of Cardiology at Daping Hospital, Army Medical University. His extensive experience includes roles such as Deputy Director, Associate Chief Physician, Attending Doctor, and Resident, reflecting his progressive career growth and expertise in cardiology and geriatrics.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Myocardial Infarction

Dr. Wang’s research is centered on new strategies for treating cardiovascular diseases, particularly myocardial infarction and heart failure. His primary areas of focus include:

  1. Mechanisms regulating cardiac regeneration.
  2. Translational and clinical studies for treating cardiovascular diseases.
  3. Translational and clinical research for preventing aging.

His work has significantly advanced the understanding of cardiac repair mechanisms and potential therapeutic interventions.

🌍IMPACT AND INFLUENCE:

Dr. Wang has played a crucial role in the field of cardiology and geriatrics. His research has contributed to innovative treatments that enhance cardiac regeneration and improve patient outcomes. As a leader in cardiovascular medicine, his influence extends beyond clinical practice to shaping future medical research and treatment methodologies.

📚ACADEMIC CITATIONS AND RECOGNITION:

Dr. Wang has an impressive list of publications in esteemed medical journals. Some of his notable works include:

  1. “Metabolic reprogramming: a byproduct or a driver of cardiomyocyte proliferation?” published in Circulation (2024).
  2. “Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ-NONO heteromer-induced DNA repair,” published in Basic Research in Cardiology (2022).
  3. “The Role of G Protein-Coupled Receptor Kinase 4 in Cardiomyocyte Injury after Myocardial Infarction,” published in European Heart Journal (2021).
  4. “Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury,” published in Circulation (2017).

These publications highlight his extensive contributions to cardiovascular research and his role in advancing medical knowledge in this domain.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Wang’s legacy is deeply rooted in his contributions to cardiovascular research, innovative treatment strategies, and leadership in geriatric medicine. As a distinguished professor and researcher, his work continues to shape the future of cardiology and geriatrics. His ongoing research and clinical innovations are expected to provide new breakthroughs in cardiac care and aging prevention, benefiting future generations of patients and medical professionals.

🚀CONCLUSION:

Prof. Wei Eric Wang is a distinguished cardiologist and geriatrician whose groundbreaking research and leadership have significantly impacted cardiovascular medicine. His dedication to innovation, patient care, and scientific discovery continues to inspire future generations. As Director of Geriatrics at Southwest Hospital, his work advances both clinical and translational medicine, improving lives worldwide. With numerous influential publications and a commitment to pioneering treatments, his contributions to cardiac regeneration and aging prevention are invaluable. His legacy in medicine and academia ensures a lasting impact, shaping the future of healthcare and research.

TOP NOTABLE PUBLICATIONS

  • Title: Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?
    Authors: Xiaokang Chen, Hao Wu, Ya Liu, Lingyan Liu, Steven R. Houser, Wei Eric Wang
    Journal: Circulation
    Year: 2024

  • Title: Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ–NONO heteromer-induced DNA repair
    Authors: Wenbin Fu, Hongmei Ren, Jialing Shou, Qiao Liao, Liangpeng Li, Yu Shi, Pedro A. Jose, Chunyu Zeng, Wei Eric Wang
    Journal: Basic Research in Cardiology
    Year: 2022

  • Title: The Protective Role of Yin‐Yang 1 in Cardiac Injury and Remodeling After Myocardial Infarction
    Authors: Yu Huang, Liangpeng Li, Hongmei Chen, Qiao Liao, Xiaoli Yang, Dezhong Yang, Xuewei Xia, Hongyong Wang, Wei Eric Wang, Lianglong Chen et al.
    Journal: Journal of the American Heart Association
    Year: 2021

  • Title: The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction
    Authors: Wei Eric Wang, Liangpeng Li, Fu W, Gong X, Chen Z, Tang L, Yang D, Liao Q, Xia X, Wu H et al.
    Journal: European Heart Journal
    Year: 2021

  • Title: An Aurora Kinase B-Based Mouse System to Efficiently Identify and Analyze Proliferating Cardiomyocytes
    Authors: Wei Eric Wang, Fu W, Liao Q, Li L, Shi Y, Zeng A, Zeng C, Wang WE
    Journal: Frontiers in Cell and Developmental Biology
    Year: 2020

  • Title: Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart
    Authors: Wei Eric Wang, Zhang Y, Wang WE, Zhang X, Li Y, Chen B, Liu C, Ai X, Zhang X, Tian Y et al.
    Journal: Circulation Research
    Year: 2019

  • Title: Noncoding RNA and Cardiomyocyte Proliferation
    Authors: Shuang Qu, Chunyu Zeng, Wei Eric Wang
    Journal: Stem Cells International
    Year: 2017

  • Title: Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury
    Authors: Wei Eric Wang, Wang WE, Li L, Xia X, Fu W, Liao Q, Lan C, Yang D, Chen H, Yue R et al.
    Journal: Circulation
    Year: 2017

  • Title: Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium
    Authors: Wei Eric Wang, Wang WE, Yang D, Li L, Wang W, Peng Y, Chen C, Chen P, Xia X, Wang H et al.
    Journal: Circulation Research
    Year: 2013

Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Posted on by Pencis

Prof. Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Prof. Zhihui Zhang, Army Medical University, China

Prof. Zhihui Zhang is a distinguished researcher at Army Medical University, China, specializing in cardiovascular diseases and stem cell therapy. His work focuses on endothelial seed cells, myocardial infarction, and immunosuppressive capabilities of mesenchymal stem cell-derived extracellular vesicles. He has published extensively in leading journals such as Genes and Diseases, Science Bulletin, and Stem Cell Research and Therapy. Prof. Zhang’s research contributes to advancing early diagnosis and targeted interventions for coronary microvascular dysfunction. His expertise in molecular biology and regenerative medicine has made significant impacts in cardiovascular research and clinical applications.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Zhihui Zhang embarked on his academic journey with a deep passion for cardiovascular medicine. His early education laid a strong foundation in medical sciences, leading him to specialize in cardiology. His dedication and excellence in research and clinical practice positioned him for advanced studies and significant contributions to the field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Zhang is the Director of the Department of Cardiology at the First Affiliated Hospital (Southwest Hospital) of the Army Medical University in Chongqing. His leadership extends beyond the hospital as he holds multiple prestigious roles:

  • Member of the Great Vessel Group under the Cardiology Branch of the Chinese Medical Association
  • Member of the Cardiologists’ Association of the Chinese Medical Doctor Association
  • Deputy Director of the Committee for Structural Heart Disease under the China Human Health Promotion Association
  • Deputy Director of the Cardiology Branch of the Chongqing Medical Association, leading the Interventional Cardiology and Imaging Group

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCH:

Dr. Zhang is renowned for his expertise in interventional treatment of coronary heart disease and structural heart disease. His research focuses on:

  • Precise diagnosis and treatment of coronary heart disease
  • Interventional therapy for valvular heart diseases
  • Establishing a cohort for precise classification of myocardial ischemia
  • Creating a biobank and an artificial intelligence center for coronary angiography physiological assessment

Additionally, he has developed the professional Circa Met DB database, specializing in metabolic circadian rhythms.

🌍IMPACT AND INFLUENCE:

Dr. Zhang’s contributions have earned him numerous accolades, including:
🏆 Two first prizes for scientific progress in Chongqing
🏆 One first prize for scientific progress in Hubei Province
🏆 One second prize for military medical achievements

He has successfully led over 20 research projects, ranging from national natural science funds to key military and Chongqing talent programs. His pioneering work in cardiology has influenced national and military healthcare policies.

📖ACADEMIC CITATIONS:

Dr. Zhang has an outstanding publication record, with more than 30 SCI papers as the first or corresponding author (including co-first/co-corresponding). His research has been featured in top-tier journals such as:
📌 The Lancet
📌 Nature Metabolism
📌 Nature Communications
📌 Trends in Cell Biology

Additionally, he has contributed to drafting and setting 12 expert consensus documents, served as a deputy editor for two monographs, and contributed to nine other books. His work extends to two national invention patents, further solidifying his impact in the field.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

As a recipient of the Outstanding Youth Talent Fund in National Defense Bioscience, Dr. Zhang is recognized as a key innovator in cardiology. He has been honored as an Innovation Leading Talent by the Chongqing Talents Program and as a Science and Technology Talent by the Army.

His legacy will continue to shape the future of cardiovascular medicine through:
✅ Advanced research in interventional cardiology
✅ Expansion of AI-driven medical diagnostics
✅ Development of groundbreaking therapeutic techniques
✅ Mentorship and training of future cardiologists

🌟CONCLUSION:

Prof. Zhihui Zhang is a visionary leader in cardiology, blending clinical excellence, groundbreaking research, and technological innovation. His contributions have not only transformed patient care but also advanced global medical knowledge. His work will undoubtedly influence generations of medical professionals and redefine the future of cardiovascular treatment.

TOP NOTABLE PUBLICATIONS

Single nucleotide polymorphisms: Implications in the early diagnosis and targeted intervention of coronary microvascular dysfunction

Authors: Dingyuan Tian, Jie Li, Qingyuan Yang, Zhihui Zhang, Fang Deng

Journal: Genes and Diseases

Year: 2025

Circadian nutrition: is meal timing an elixir for fatigue?

Authors: Zhihui Zhang, Lu Yan, Jonas T. Treebak, Min-Dian Li

Journal: Science Bulletin

Year: 2025

Foxo1 drives the TGFβ1-dependent dichotomy of Th17 cell fates

Authors: Mengjuan Zhang, Yude Guan, Meijuan Han, Xiaomin Zhang, Song Zhang

Journal: Journal of Leukocyte Biology

Year: 2025

The short-term outcomes and risk factors of post-myocardial infarction ventricular septal rupture: a multi-center retrospective study

Authors: Wenjian Luo, Li Wen, Jinning Zhang, Zhexue Qin, Shiyong Yu

Journal: Journal of Cardiothoracic Surgery

Year: 2024

Sources and applications of endothelial seed cells: a review

Authors: Dan Deng, Yu Zhang, Bo Tang, Zhihui Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis

Authors: Yanan Duan, Xiteng Chen, Hui Shao, Jiawei Wang, Xiaomin Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Authors: Junjie Tang, Yaoming Liu, Yinghao Wang, Ping Zhang, Rong Lu

Journal: Biomarker Research

Year: 2024

Associations between non-insulin-based insulin resistance indices and heart failure prevalence in overweight/obesity adults without diabetes mellitus: evidence from the NHANES 2001–2018

Authors: Diyu Cui, Chao Zhang, Yi Chen, Yu Zhang, Ping Zhu

Journal: Lipids in Health and Disease

Year: 2024

Single-cell transcriptomics enable the characterization of local extension in retinoblastoma

Authors: Yaoming Liu, Wei Hu, Yanjie Xie, Shengli Li, Rong Lu

Journal: Communications Biology

Year: 2024

Clinical characteristics of patients with moderate or severe valvular heart disease

Authors: Hao Gao, Yuzhu Lei, Haiyun Huang, Yanxiu Chen, Zhihui Zhang

Journal: Chinese Journal of Cardiology

Year: 2024

XIngcheng Yi | Myocardial tissue repair | Best Researcher Award

Posted on by Pencis

🎓Current Position:

Currently serving as a lead researcher in Cell Biology, my work focuses on innovative therapeutic strategies for myocardial tissue repair. Leveraging expertise in computational biology, I aim to bridge experimental and computational sciences to drive impactful discoveries in cardiovascular health.

📚Academic Background:

Earned a Ph.D. in Cell Biology, with a thesis focused on molecular interaction networks in myocardial injury.
Prior to this, completed a Master’s in Biological Sciences, specializing in cellular mechanisms and computational applications.

📝Publications Achievements:

Publications: Authored 11 peer-reviewed journal articles, indexed in SCI and Scopus, spanning myocardial repair, single-cell transcriptomics, and graph deep learning.
Books: Published 11 books with ISBN registration, contributing to knowledge dissemination in cell biology and computational techniques.
Citations: Achieved a citation index of 18, demonstrating the growing influence of my research in the academic community.
Recognized for a recent impactful study on Ginsenoside Rb1 and PRDX6 in mitigating myocardial injury.

🔬Ongoing Research Projects:

Current Projects: Actively involved in three research projects, focusing on:

  1. Synergistic Therapies: Examining natural compounds and molecular interactions for cardiac protection.
  2. Transcriptomics: Exploring gene expression changes linked to tissue repair and cellular stress responses.
  3. Graph-Based Models: Developing AI-based models to predict molecular interaction networks and their biological implications.

Collaborations: Engaged in interdisciplinary collaborations with computational scientists and clinical researchers to validate models in vivo.

🔍Research Interests:

Areas of expertise and passion include:

  • Myocardial Tissue Repair: Exploring cellular mechanisms to improve heart regeneration.
  • Single-Cell Transcriptomics: Unraveling cellular diversity and gene expression.
  • Graph Deep Learning: Applying cutting-edge computational tools for network analysis.
  • Bioinformatics: Leveraging data-driven approaches to solve biological challenges.

🏆Awards and Scholarships:

Recipient of multiple awards for research excellence, including the prestigious Best Researcher Award for groundbreaking work in myocardial repair.
Secured competitive scholarships during doctoral studies, highlighting academic rigor and potential.

🎤Professional Associations:

Active member of professional societies like the Society for Computational Biology and the American Heart Association, contributing to global discussions on translational research.

🎓Training & Workshops: 

Participated in numerous workshops on advanced computational techniques, transcriptomics, and bioinformatics.
Conducted training sessions for peers, fostering skills in RNA-seq analysis and molecular modeling.

🧪Laboratory Experience and Publications: 

Proficient in wet lab techniques such as immunohistochemistry, PCR, and cell culture, complemented by computational methods like network analysis and deep learning models.
Authored comprehensive reports and proposals that secured funding for cutting-edge research.

🛠️Tasks Completed as a Researcher:

Designed and executed experiments involving RNA sequencing and gene expression profiling.
Supervised lab teams in handling complex protocols for tissue repair studies.
Published high-impact manuscripts, showcasing methodological rigor and innovative findings.

🎤Oral Presentations:

Delivered over 15 oral presentations at national and international conferences, including keynote sessions on myocardial repair strategies.
Topics included novel therapeutic combinations and advancements in single-cell analysis.

🌟Success Factors:

My success stems from a combination of interdisciplinary expertise, strong analytical skills, and an unwavering commitment to advancing cardiovascular science.
Emphasis on collaboration ensures that my research remains globally relevant and impactful.

🌍Conclusion: 

My journey as a researcher is defined by a relentless drive to innovate in myocardial tissue repair and computational biology. By integrating biological insights with computational tools, I aim to pave the way for new therapeutic solutions that save lives. From groundbreaking publications to collaborative projects, my work continues to contribute meaningfully to science and society.

Top Notable Publications:

Article: Hypoxia adaptation mechanism in rats’ peripheral auditory system in high altitude migration: a time series transcriptome analysis
Authors: Wang, L., Yi, X., Zhou, Y., Su, X., Wang, P.
Year: 2024
Journal: Scientific Reports
Citations: 0

Letter: Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study
Authors: Zhang, Y., Liang, X., Xu, W., Dai, Y., Jin, F.
Year: 2024
Journal: Journal of Hematology and Oncology
Citations: 1

Article: Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis
Authors: Xu, W., Liang, X., Liu, S., Dai, Y., Jin, F.
Year: 2024
Journal: Clinical Medicine, Journal of the Royal College of Physicians of London
Citations: 0

Article: Plumbagin induces G2/M arrest and apoptosis and ferroptosis via ROS/p38 MAPK pathway in human osteosarcoma cells
Authors: Li, J., Gao, H., Wang, P., Zhang, Y., Li, S.
Year: 2024
Journal: Alexandria Engineering Journal
Citations: 1

Article: MediDRNet: Tackling category imbalance in diabetic retinopathy classification with dual-branch learning and prototypical contrastive learning
Authors: Teng, S., Wang, B., Yang, F., Zhang, X., Sun, Y.
Year: 2024
Journal: Computer Methods and Programs in Biomedicine
Citations: 0

Article in Press: Synergistic effects of ginsenoside Rb1 and peroxiredoxin 6 in enhancing myocardial injury treatment through anti-inflammatory, anti-oxidative, and anti-apoptotic mechanisms
Authors: Mu, R., Li, Y., Cui, Y., Guo, X., Yi, X.
Year: 2024
Journal: Journal of Ginseng Research
Citations: 0

Letter: More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
Authors: Tian, M., Liang, X., Xu, W., Dai, Y., Jin, F.
Year: 2023
Journal: Annals of Hematology
Citations: 0

Letter: Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma
Authors: Yang, P., Xu, W., Liang, X., Dai, Y., Jin, F.
Year: 2023
Journal: American Journal of Hematology
Citations: 3

Article: Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma
Authors: Yang, P., Chen, H., Liang, X., Dai, Y., Jin, F.
Year: 2023
Journal: American Journal of Hematology
Citations: 7

Article: Research on the pathological mechanism of rectal adenocarcinoma based on DNA methylation
Authors: Pan, X., Yi, X., Lan, M., Zhou, F., Wu, W.
Year: 2023
Journal: Medicine (United States)
Citations: 2